Search results for "Infectious Diseases"
Nirmatrelvir/ritonavir rarely leads to rebound, doesn't help average-risk patients, studies find
A retrospective analysis found that symptom rebound occurred in less than 1% of high-risk COVID-19 patients treated with nirmatrelvir/ritonavir, while the manufacturer reported that the drug didn't show significant benefit in average-risk patients.
21 Jun 2022
Register now for ACP and Annals of Internal Medicine's COVID-19 Forum VIII: Outpatient Evaluation and Management of Patients with COVID-19
During the Feb. 9 virtual live event, a panel of experts will discuss appropriate COVID-19 testing, quarantine and isolation periods, management of symptoms, and recommended treatments in the outpatient setting.
1 Feb 2022
Register now for ACP and Annals of Internal Medicine's COVID-19 Forum VII: Challenging Clinical Questions
During the Dec. 8 virtual live event, a panel of experts will provide answers to common questions about COVID-19 that physicians face today.
23 Nov 2021
Register now for next ACP, Annals of Internal Medicine forum on COVID-19
On Oct. 8, panelists will provide insight on the clinical implications of the immunology of SARS-CoV-2 and the COVID-19 vaccine, including the status of booster doses and the efficacy of vaccination in various groups.
5 Oct 2021
ACP, Annals of Internal Medicine host ‘Monkeypox: Challenging Clinical Questions’
The virtual forum featured a panel of physicians providing answers to commonly asked questions about the human monkeypox virus and is available for replay online.
18 Oct 2022
New best practice guidance encourages stewardship of urine culture orders
A panel of 15 experts offered recommendations for diagnostic stewardship of urine cultures, including strategies for ordering, processing, and reporting cultures in the ED, hospital, outpatient practice, and long-term care.
7 Dec 2021
IDSA releases guidance on antibiotic selection for gram-negative antimicrobial-resistant bacterial infections
New treatment guidance from the Infectious Diseases Society of America (IDSA) focused on extended-spectrum beta-lactamase-producing Enterobacterales, carbapenem-resistant Enterobacterales, and Pseudomonas aeruginosa with difficult-to-treat resistance.
15 Sep 2020
New data on COVID-19 vaccines' effectiveness against omicron, among immunocompromised
One English analysis showed how COVID-19 boosters increase protection against symptomatic infection from omicron, while two studies looked at vaccinating the immunocompromised, and ACP videos worked to educate patients and increase vaccine uptake.
8 Mar 2022
Clinician education, feedback led to fewer inappropriate antibiotics for respiratory tract infections
A stepped-wedge cluster randomized study in 31 primary care practices found that the proportion of visits with an antibiotic prescription decreased from 35.2% to 23.0% after an intervention involving clinician education and monthly peer comparison feedback.
13 Jul 2021
Two studies show effectiveness of mRNA boosters against omicron variant
Other recent research on COVID-19 revealed the high transmissibility of the omicron stealth variant and changes in the brain after SARS-CoV-2 infection.
15 Mar 2022